Home > Publications > Presentations

Posters & Abstracts

2017
Bonakdar et al.
Personalized Medicine Summit
Comprehensive Bioinformatics Analysis of Whole Genome and Transcriptome Sequence Data from Individual Patient Tumours
2017
Chooback et al
CAMO
Whole genome sequencing (WGS) analysis of lung adenocarcinoma: elucidating the molecular signature
2017
Jones et al
AGBT
Taking whole genomes to the cancer clinic: Integrative analysis for interpretation and communication of whole genome and transcriptome analysis at a tumour board
2017
Lim et al.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology
2017
Ma et al.
AGBT
Bioinformatics for Personalized Oncogenomics: Lessons learned from analyzing whole genomes and transcriptomes from 500 patients
2017
Pearson et al.
4th Canadian Cancer Research Conference
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort
2017
Pleasance et al
Personalized Medicine Summit
Personalized Oncogenomics: Whole Genome and Transcriptome Sequencing Informs Treatment Decisions in the Cancer Clinic
2017
Shen et al
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Clinical application of whole genome and transcriptome sequencing in cancer care
2017
Tsang et al
ASCO
Clinical Outcomes after Whole Genome Sequencing in Patients with Metastatic Non Small Cell Lung Cancer
2017
Yang et al.
B.I.G Research Day at UBC
Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing
2017
Yang et al.
MBB Graduate Colloquium
Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing
2017
Yaoqing Shen
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics
Clinical application of whole genome and transcriptome sequencing in cancer care
2017
Zhao et al.
AACR
Breast Cancer Whole Genomes Link Homologous Recombination Deficiency (HRD) with Therapeutic Outcomes
2016
Grewal et al.
TFRI- Node
Using machine learning to identify site of origin of metastatic tumours
2016
Ho et al.
ESMO
The incorporation of tumor whole genome sequencing in practice: The impact on clinical decision-making and therapeutic choices)
2016
Jones et al.
AGBT
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies
2016
Laskin et al.
AACR
Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care
2016
Laskin et al.
ESMO
Availability of tumour gene expression data facilitates clinical decision-making for patients with advanced cancers.
2016
Laskin et al.
ESMO
Clinicians identify high need to increase their genomic literacy to applied cancer genomics.
2016
Lever et al.
Biocreative conference
CancerMine: A knowledgebase of cancer drivers for personalised cancer treatment
2016
Schrader et al.
AACR
Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis
2016
The POG team
ASCO
Watson Genomic Analytics efficiently interprets whole genome sequencing data from cancer patients with advanced disease at high throughput
2016
Zhao et al.
CITAC
Guiding Platinum-based Chemotherapy in Breast Cancer with a Somatic Mutation Signature of Homologous Recombination Deficiency
2015
Bose et al.
AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy
Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma
2015
Fok et al.
Canadian GE3LS and Health Services & Policy Research Conference
Management of Germline Findings Revealed Throughout the Course of Tumor-Normal Whole Genome Sequencing in Oncology
2015
Jones et al.
Personalized Medicine Summit
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies
2015
Koyama et al.
American Society of Human Genetics
Case Analysis of Advanced Cancers with Watson Genomic Analytics
2015
Lim et al.
ESMO
Management of Germline Findings Revealed Throughout the Course of Tumor-Normal Whole Genome Sequencing in Oncology
2015
Ma et al.
AGBT
A bioinformatics pipeline for analyzing whole genome and transcriptome sequence data from individual patient tumours
2015
Moore et al.
AGBT
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies
2015
Rassekh et al.
ASPHO
Pediatric Personalized Oncogenomics (PedsPOG) – Initial outcomes
2015
Roscoe et al.
Personalized Medicine Summit
Management of a large -scale personalized medicine project
2015
Sun et al.
AACR
Personalized OncoGenomic in advance stage breast cancer
2015
Yip et al.
USCAP
Next Generation Pathology: The Integration of Next Generation Sequencing With Glass-Based Histomorphology and Immunohistochemistry
2015
Zhao et al.
Clinician Investigator Program Research Fellow Day
Searching for Targetable Mutation Signatures in a Mixed Cancer Cohort
2015
Zhao et al.
Personalized Medicine Summit
Searching for Targetable Mutation Signatures in a Mixed Cancer Cohort
2014
Jones et al
7th Annual RECOMB/ISCB Conference on  Regulatory & Systems Genomics with DREAM Challenges
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies
2014
Jones et al.
TFRI- Node
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies
2014
Kasaian et al.
AACR
Bioinformatic Analyses Approaches for Personalized Oncogenomics
2014
Laskin et al.
AACR
Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies
2014
Lim et al.
ESMO
Practical guidance for ethical and policy issues that arise from the clinical application of whole genome sequencing in cancer patients
2014
Mungall et al.
3rd TCGA Symposium
Using TCGA data to inform on precision medicine in late-stage cancer settings
2014
Rassekh et al.
TFRI- Node
Pediatric Personalized Oncogenomics(PEDSPOG) – Initial outcome
2014
Zhao et al
Clinician Investigator Trainee Association of Canada Annual General Meeting
Networks, signatures, and personalized medicine: a whole genome approach to cancer therapy
2012
Li et al.
TFRI- Node
Utilization of genomic information to help guide personalized therapy decision making in patients with incurable malignancies!